Riskpilot← Back to searchSign inGet full accessTRONDHEIM HJERTESENTER AS
ASActiveOrg 976542495Havnegata 7, 7010 TrondheimMedical specialists activities · NACE 8622Est. 19963 employees
Revenue 2025
NOK 8,2M
+22% vs 2024
EBITDA margin
59.3%
+46% vs 2024
Equity ratio
1.8%
Financial strength
Net profit 2025
NOK 3,9M
+44% vs 2024
| Revenue | NOK 8,2M | +22% |
| EBITDA | NOK 4,9M | +46% |
| Net profit | NOK 3,9M | +44% |
| Total assets | NOK 5,5M | +38% |
| Equity | NOK 100K | -55% |
| Employees | 3 | — |
Legal name
TRONDHEIM HJERTESENTER AS
Org number
976542495
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
10. januar 1996
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Drive med alle former for helsetjenester, rådgiving og ellers hva som måtte stå i denne sammenheng.
Address
Havnegata 7, 7010 Trondheim
Phone
+4745381202
Email
resepsjon@trondheimhjertesenter.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 874 | 6 104 | 6 422 | 6 751 | 8 202 |
| Staff expenses | −1 636 | −1 641 | −1 671 | −1 771 | −1 825 |
| EBITDA | 2 846 | 2 914 | 3 078 | 3 339 | 4 863 |
| Depreciation & amort. | −28 | −28 | −11 | −12 | −46 |
| EBIT | 2 819 | 2 887 | 3 067 | 3 327 | 4 817 |
| Net financials | 0 | 6 | 53 | 95 | 117 |
| Profit before tax | 2 819 | 2 892 | 3 120 | 3 423 | 4 934 |
| Tax | 614 | 632 | 681 | 741 | 1 082 |
| Net profit | 2 205 | 2 260 | 2 439 | 2 682 | 3 852 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 726 | 3 552 | 3 696 | 3 987 | 5 509 |
| Equity | 283 | 143 | 142 | 224 | 100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 443 | 3 409 | 3 554 | 3 763 | 5 409 |
| Total debt | 3 443 | 3 409 | 3 554 | 3 763 | 5 409 |
EBITDA margin
59.3%
This company
15.8%
Market median
+275% vs market
20212025
Equity ratio
1.8%
This company
38.2%
Market median
-95% vs market
20212025
Return on equity
3846.9%
This company
18.4%
Market median
+20807% vs market
20212025
Net profit margin
47.0%
This company
8.1%
Market median
+480% vs market
20212025
Asset turnover
1.49×
This company
1.12×
Market median
+33% vs market
20212025
Debt / equity
54.02×
This company
0.62×
Market median
-8613% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ylvind Holding As
TRONDHEIM HJERTESENTER AS Board members of TRONDHEIM HJERTESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Olav Haugen | Chairman | 0 companies |
| Lene Kristin Nagelhus | Board of Directors | 0 companies |